Published • loading... • Updated
Weekly Cladribine Plus Rituximab Shows Promise Against Hairy Cell Leukemia
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGWeekly Cladribine Plus Rituximab Shows Promise Against Hairy Cell Leukemia
A weekly dosing schedule for a decades-old leukemia drug appears to outperform the standard daily infusion regimen in hairy cell leukemia, delivering dramatically higher remission rates and keeping patients in remission longer, all while sending fewer of them to the hospital. A retrospective study of 36 patients treated at the University of Colorado Hospital over […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
